In Brief: Torrent buys Elder, studies supporting claims must be relevant, common ingredient names on labels, enzyme supplement guidance
This article was originally published in The Tan Sheet
Executive Summary
Torrent buys Elder; studies supporting claims must match dose, form – NAD; labels must carry common ingredient names; street drug alternative claims; CRN, ETA publish enzyme guidance; EMA prioritizes 2014 work program; and natural personal care market nears $30 billion.